Vogenx is a clinical stage drug development company focusing on treatment of diseases associated with dysfunctions in human metabolism
Vogenx has raised $750K in total funding. The most recent round was Debt Financing. The last funding was announced in January 2026.
Vogenx is headquartered in Durham, United States.
Vogenx is a clinical stage drug development company focusing on treatment of diseases associated with dysfunctions in human metabolism
Vogenx is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vogenx — Funding & Investors." VCBacked, January 6, 2026, https://www.vcbacked.co/company/vogenx. Accessed September 30, 2026.
VCBacked. (2026). Vogenx — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/vogenx
{{cite web |title=Vogenx — Funding & Investors |url=https://www.vcbacked.co/company/vogenx |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated